[Good syndrome: a rare, unusual immunodeficiency condition]

Area of Science:

• Immunology
• Oncology
• Genetics

Context:

• Good syndrome is a rare clinical entity characterized by the co-occurrence of thymoma and immunodeficiency.
• First described 70 years ago, it presents with increased susceptibility to infections, autoimmunity, and malignancies.
• Patients are typically middle-aged, with hypogammaglobulinemia and reduced B cells being consistent immunological findings.

Purpose:

• To review the characteristics, diagnosis, and management of Good syndrome.
• To highlight the complex interplay between thymoma and the immune system in its pathogenesis.
• To discuss current therapeutic recommendations and the need for further research into its etiology.

Summary:

• Good syndrome involves thymoma and acquired combined (T, B) immunodeficiency, often presenting as a phenocopy with heterogeneous clinical features.
• The thymoma, usually benign, alters the thymus microenvironment, contributing to immunodeficiency and autoimmunity.
• Etiopathogenesis is unclear, potentially involving epigenetic and genetic factors; current treatment focuses on thymectomy, infection control, and immunoglobulin replacement.

Impact:

• Improved understanding of Good syndrome's complex pathophysiology.
• Enhanced diagnostic approaches for this challenging condition.
• Guidance on current management strategies and areas for future research.